20 November 2020 in Nature Communications
Identifying pathogenic variants and underlying functional alterations is challenging. To this end, we introduce MutPred2, a tool that improves the prioritization of pathogenic amino acid substitutions over existing methods, generates molecular mechanisms potentially causative of disease, and returns interpretable pathogenicity score distributions on individual genomes. Whilst its prioritization performance is state-of-the-art, a distinguishing feature of MutPred2 is the probabilistic modeling of variant impact on specific aspects of protein structure and function that can serve to guide experimental studies of phenotype-altering variants. We demonstrate the utility of MutPred2 in the identification of the structural and functional mutational signatures relevant to Mendelian disorders and the prioritization of de novo mutations associated with complex neurodevelopmental disorders. We then experimentally validate the functional impact of several variants identified in patients with such disorders. We argue that mechanism-driven studies of human inherited disease have the potential to significantly accelerate the discovery of clinically actionable variants.
3 September 2009 in Bioinformatics
Motivation: Advances in high-throughput genotyping and next generation sequencing have generated a vast amount of human genetic variation data. Single nucleotide substitutions within protein coding regions are of particular importance owing to their potential to give rise to amino acid substitutions that affect protein structure and function which may ultimately lead to a disease state. Over the last decade, a number of computational methods have been developed to predict whether such amino acid substitutions result in an altered phenotype. Although these methods are useful in practice, and accurate for their intended purpose, they are not well suited for providing probabilistic estimates of the underlying disease mechanism. Results: We have developed a new computational model, MutPred, that is based upon protein sequence, and which models changes of structural features and functional sites between wild-type and mutant sequences. These changes, expressed as probabilities of gain or loss of structure and function, can provide insight into the specific molecular mechanism responsible for the disease state. MutPred also builds on the established SIFT method but offers improved classification accuracy with respect to human disease mutations. Given conservative thresholds on the predicted disruption of molecular function, we propose that MutPred can generate accurate and reliable hypotheses on the molecular basis of disease for ∼11% of known inherited disease-causing mutations. We also note that the proportion of changes of functionally relevant residues in the sets of cancer-associated somatic mutations is higher than for the inherited lesions in the Human Gene Mutation Database which are instead predicted to be characterized by disruptions of protein structure. Availability:http://mutdb.org/mutpred Contact:predrag@indiana.edu; smooney@buckinstitute.org
13 January 2014 in Genome Biology
We have developed a novel machine-learning approach, MutPred Splice, for the identification of coding region substitutions that disrupt pre-mRNA splicing. Applying MutPred Splice to human disease-causing exonic mutations suggests that 16% of mutations causing inherited disease and 10 to 14% of somatic mutations in cancer may disrupt pre-mRNA splicing. For inherited disease, the main mechanism responsible for the splicing defect is splice site loss, whereas for cancer the predominant mechanism of splicing disruption is predicted to be exon skipping via loss of exonic splicing enhancers or gain of exonic splicing silencer elements. MutPred Splice is available at http://mutdb.org/mutpredsplice.
9 December 2022 in Nature Communications
Synthetic health data have the potential to mitigate privacy concerns in supporting biomedical research and healthcare applications. Modern approaches for data generation continue to evolve and demonstrate remarkable potential. Yet there is a lack of a systematic assessment framework to benchmark methods as they emerge and determine which methods are most appropriate for which use cases. In this work, we introduce a systematic benchmarking framework to appraise key characteristics with respect to utility and privacy metrics. We apply the framework to evaluate synthetic data generation methods for electronic health records data from two large academic medical centers with respect to several use cases. The results illustrate that there is a utility-privacy tradeoff for sharing synthetic health data and further indicate that no method is unequivocally the best on all criteria in each use case, which makes it evident why synthetic data generation methods need to be assessed in context.
21 August 2018 in Depression and Anxiety
9 August 2018 in Journal of Medical Internet Research
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Most people with mental health disorders fail to receive timely access to adequate care. Digital technology has the potential to drive a sea change in the psychosocial treatment of mental health problems, especially in minority populations that have known barriers to accessing and utilizing traditional treatment approaches. Objective: The objective of the present study was to compare recruitment, engagement, and treatment outcomes between a sample of depressed Spanish-speaking Hispanic/Latino individuals compared to a cohort of depressed English speakers using 3 different self-guided mobile apps (iPST (based on evidence-based therapeutic principles from problem-solving therapy [PST]); Project: Evolution™ (EVO; a cognitive training app based on cognitive neuroscience principles); and Health Tips (health information app that served as an information control)). Methods: Participants were recruited for this randomized controlled trial using social media platforms, internet-based advertisements, and traditional fliers in select locations in each state across the United States. Assessment and self-guided treatment was conducted on each participant's smartphone or tablet. We enrolled 646 English-speaking and 437 Spanish-speaking adults (≥18 years old) with mild to moderate depression as determined by a 9-item Patient Health Questionnaire (PHQ-9) score ≥5 or an endorsement of impaired functioning. Outcomes were depressive symptom severity (measured using PHQ-9) and functional impairment (assessed with Sheehan Disability Scale). Engagement in the study was assessed based on the number of times participants completed active surveys. Results: We screened 4,502 participants and enrolled 1,083 participants from throughout the US over 6 months. The majority of the participants were recruited via posts on craigslist.org, with significant participant acquisition costs present when recruiting Spanish speakers ($31/ participant) compared to English speakers ($1.46/participant). Long-term engagement surfaced as a key issue with Spanish speaking participants, as these individuals dropped out two weeks earlier than their English counterparts. Furthermore, while no significant difference between Spanish- and English speakers were observed for treatment remission, Spanish-speakers consistently reported higher depression symptoms compared to their English speaking counterparts. Conclusions: Our findings suggest that fully remote mobile-based studies can attract a diverse participant pool including people from lower socioeconomic backgrounds (in this case Hispanic/Latinos). However, keeping participants engaged in this type of ‘low-touch’ research study remains challenging. Further research including user-centered approaches are needed to understand the culturally adequate incentive levels, notification strategies and effective mobile content formatting to enhance the recruitment and retention of minority populations. Clinical Trial: Clinicaltrials.gov Identifier: NCT01808976